18F-FDG and 68Ga-FAPI-04 in the Evaluation of Aggressive Perivascular Epithelioid Cell Tumor

被引:7
作者
Zhang, Zeyu [1 ]
Yu, Yongwei [2 ]
Zhang, Lu [1 ]
Cheng, Chao [1 ]
Zuo, Changjing [1 ]
机构
[1] Navy Mil Med Univ, Dept Nucl Med, Changhai Hosp, Shanghai, Peoples R China
[2] Navy Mil Med Univ, Dept Pathol, Changhai Hosp, Shanghai, Peoples R China
关键词
F-18-FDG; Ga-68-FAPI-04; PEComa; PET/CT; PET/MRI; PECOMAS;
D O I
10.1097/RLU.0000000000004249
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 10-year-old girl with a right renal mass underwent 18F-FDG PET/CT and 68Ga-FAPI-04 PET/MRI for presurgical assessment of tumor invasion and malignant potential. The mass showed low 18F-FDG uptake and intense 68Ga-FAPI-04 uptake. Nephrectomy was performed, and the histopathologic diagnosis was aggressive PEComa (perivascular epithelioid cell tumor). This case showed that 68Ga-FAPI-04 PET outperformed 18F-FDG PET in detecting aggressive PEComa. © 2022 Wolters Kluwer Health, Inc.
引用
收藏
页码:897 / 899
页数:3
相关论文
共 50 条
  • [21] Comparison of the diagnostic efficacy of 68Ga-FAPI-04 PET/MR and 18F-FDG PET/CT in patients with pancreatic cancer
    Zhang, Zeyu
    Jia, Guorong
    Pan, Guixia
    Cao, Kai
    Yang, Qinqin
    Meng, Hongyu
    Yang, Jian
    Zhang, Lu
    Wang, Tao
    Cheng, Chao
    Zuo, Changjing
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (08) : 2877 - 2888
  • [22] 68Ga-FAPI-04 PET for Surveillance of Anastomotic Recurrence in Postoperative Patients with Gastrointestinal Cancer: a Comparative Study with 18F-FDG PET
    Xiang Li
    Wenhui Ma
    Min Wang
    Zhiyong Quan
    Mingru Zhang
    Jiajun Ye
    Guiyu Li
    Xiang Zhou
    Taoqi Ma
    Junling Wang
    Weidong Yang
    Yongzhan Nie
    Jing Wang
    Fei Kang
    Molecular Imaging and Biology, 2023, 25 : 857 - 866
  • [23] The Superiority of 68 Ga-FAPI-04 over 18F-FDG in a Case of Gallbladder Cancer
    Chunmei Guo
    Dengsai Peng
    Ya Liu
    Liming Chen
    Zhanwen Huang
    Nuclear Medicine and Molecular Imaging, 2022, 56 : 252 - 255
  • [24] 68Ga-FAPI-04 PET/CT Imaging of Mesenteric Aggressive Fibromatosis
    Wei, Jing
    Chen, Xiaoliang
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : 664 - 665
  • [25] 68Ga-FAPI-04 PET/CT in Epithelioid Hemangioendothelioma With Pleura and Bone Metastases
    Chen, Jie
    Li, Chongjiao
    Tian, Yueli
    Wen, Bing
    He, Yong
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (10) : E654 - E655
  • [26] Value of Semi-Quantitative Parameters of 68Ga-FAPI-04 PET/CT in Primary Malignant and Benign Diseases: A Comparison with 18F-FDG
    Li, Tianyue
    Liu, Yunuan
    Dai, Meng
    Zhao, Xiujuan
    Han, Jingya
    Zhang, Zhaoqi
    Jing, Fenglian
    Tian, Weiwei
    Zhang, Jingmian
    Zhao, Xinming
    Wang, Jianfang
    Hao, Tiancheng
    Wang, Tingting
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (09) : 654 - 663
  • [27] Utility of 68Ga-FAPI-04 PET/CT in Adenoid Cystic Carcinoma Compared With 18F-FDG PET/CT Two Case Reports
    Civan, Caner
    Isik, Emine Goknur
    Simsek, Duygu Has
    Buyukkaya, Fikret
    Kuyumcu, Serkan
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (07) : E350 - E352
  • [28] 68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT
    Komek, Halil
    Can, Canan
    Guzel, Yunus
    Oruc, Zeynep
    Gundogan, Cihan
    Yildirim, Ozgen Ahmet
    Kaplan, Ihsan
    Erdur, Erkan
    Yildirim, Mehmet Serdar
    Cakabay, Bahri
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (06) : 744 - 752
  • [29] 68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT
    Halil Kömek
    Canan Can
    Yunus Güzel
    Zeynep Oruç
    Cihan Gündoğan
    Özgen Ahmet Yildirim
    İhsan Kaplan
    Erkan Erdur
    Mehmet Serdar Yıldırım
    Bahri Çakabay
    Annals of Nuclear Medicine, 2021, 35 : 744 - 752
  • [30] 18F-FDG and 68Ga-FAPI-04 PET/CT Imaging of a Case With Immunoglobulin G4-Related Disease Presenting as Hepatic Masses
    Zhang, Zeyu
    Jiang, Hui
    Zhang, Lu
    Cheng, Chao
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (12) : 1092 - 1094